These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 28544684)

  • 1. Insulin glulisine for continuous subcutaneous insulin infusion in pediatric type 1 diabetes.
    Urakami T; Mine Y; Aoki M; Okuno M; Suzuki J
    Pediatr Int; 2017 May; 59(5):647-649. PubMed ID: 28544684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin glulisine compared to insulin aspart and to insulin lispro administered by continuous subcutaneous insulin infusion in patients with type 1 diabetes: a randomized controlled trial.
    van Bon AC; Bode BW; Sert-Langeron C; DeVries JH; Charpentier G
    Diabetes Technol Ther; 2011 Jun; 13(6):607-14. PubMed ID: 21457066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the effect of insulin glulisine to insulin aspart on breakfast postprandial blood glucose levels in children with type 1 diabetes mellitus on multiple daily injections.
    Cemeroglu AP; Kleis L; Wood A; Parkes C; Wood MA; Davis AT
    Endocr Pract; 2013; 19(4):614-9. PubMed ID: 23425652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term use of continuous subcutaneous insulin infusion compared with multiple daily injections of glargine in pediatric patients.
    García-García E; Galera R; Aguilera P; Cara G; Bonillo A
    J Pediatr Endocrinol Metab; 2007 Jan; 20(1):37-40. PubMed ID: 17315527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of rapid-acting insulin analogues in the treatment of patients with type 1 and type 2 diabetes mellitus: insulin pump therapy versus multiple daily injections.
    Bode BW
    Clin Ther; 2007; 29 Suppl D():S135-44. PubMed ID: 18191065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benefits of continuous subcutaneous insulin infusion in type 1 diabetes previously treated with multiple daily injections with once-daily glargine and pre-meal analogues.
    Torres I; Ortego J; Valencia I; García-Palacios MV; Aguilar-Diosdado M
    Exp Clin Endocrinol Diabetes; 2009 Sep; 117(8):378-85. PubMed ID: 19629931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Feasibility of continuous subcutaneous insulin infusion and daily supplemental insulin glargine injection in children with type 1 diabetes.
    Alemzadeh R; Parton EA; Holzum MK
    Diabetes Technol Ther; 2009 Aug; 11(8):481-6. PubMed ID: 19698060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Indications for the use of continuous subcutaneous insulin infusion in pediatric patients with type 1 diabetes mellitus].
    Espejel-Huerta D; Antillón-Ferreira CA; Iglesias-Leboreiro J; Bernárdez-Zapata I; Martínez-Ramos Méndez A; Rendón-Macías ME
    Rev Med Inst Mex Seguro Soc; 2016; 54(1):64-9. PubMed ID: 26820201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of switching to insulin glulisine from other rapid-acting insulin analogs in children with type 1 diabetes.
    Urakami T; Kuwabara R; Habu M; Okuno M; Suzuki J; Takahashi S
    J Diabetes Investig; 2015 Jan; 6(1):87-90. PubMed ID: 25621137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of insulins glulisine and aspart on postprandial glycemia after a high-glycemic index meal in children with type 1 diabetes.
    Dzygalo K; Szypowska A
    Eur J Endocrinol; 2014 Apr; 170(4):539-45. PubMed ID: 24412929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fields of application of continuous subcutaneous insulin infusion in the treatment of diabetes and implications in the use of rapid-acting insulin analogues.
    Pitocco D; Rizzi A; Scavone G; Tanese L; Zaccardi F; Manto A; Ghirlanda G
    Minerva Endocrinol; 2013 Sep; 38(3):321-8. PubMed ID: 24126552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term benefits of continuous subcutaneous insulin infusion in children with Type 1 diabetes: a 4-year follow-up.
    Sulli N; Shashaj B
    Diabet Med; 2006 Aug; 23(8):900-6. PubMed ID: 16911629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Switching to multiple daily injection therapy with glulisine improves glycaemic control, vascular damage and treatment satisfaction in basal insulin glargine-injected diabetic patients.
    Yanagisawa K; Ashihara J; Obara S; Wada N; Takeuchi M; Nishino Y; Maeda S; Ishibashi Y; Yamagishi S
    Diabetes Metab Res Rev; 2014 Nov; 30(8):693-700. PubMed ID: 24639403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin glulisine.
    Cox SL
    Drugs Today (Barc); 2005 Jul; 41(7):433-40. PubMed ID: 16193096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Continuous subcutaneous insulin infusion in children less than 6 years-old: long-term progress].
    Colino E; Martín Frías M; Roldán B; Álvarez MÁ; Yelmo R; Barrio R
    An Pediatr (Barc); 2017 Nov; 87(5):276-283. PubMed ID: 28233713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combining insulins for optimal blood glucose control in type I and 2 diabetes: focus on insulin glulisine.
    Ulrich H; Snyder B; Garg SK
    Vasc Health Risk Manag; 2007; 3(3):245-54. PubMed ID: 17703632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved Postprandial Glycemic Control with Faster-Acting Insulin Aspart in Patients with Type 1 Diabetes Using Continuous Subcutaneous Insulin Infusion.
    Bode BW; Johnson JA; Hyveled L; Tamer SC; Demissie M
    Diabetes Technol Ther; 2017 Jan; 19(1):25-33. PubMed ID: 28055230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The importance of anti-insulin antibody in patients with type 1 diabetes mellitus treated with continuous subcutaneous insulin infusion or multiple daily insulin injections therapy.
    Sahin SB; Cetinkalp S; Ozgen AG; Saygili F; Yilmaz C
    Acta Diabetol; 2010 Dec; 47(4):325-30. PubMed ID: 20842389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Continuous subcutaneous insulin infusion benefits quality of life in preschool-age children with type 1 diabetes mellitus.
    Opipari-Arrigan L; Fredericks EM; Burkhart N; Dale L; Hodge M; Foster C
    Pediatr Diabetes; 2007 Dec; 8(6):377-83. PubMed ID: 18036064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuous subcutaneous insulin infusion versus multiple daily injections in pregnant women with type 1 diabetes.
    González-Romero S; González-Molero I; Fernández-Abellán M; Domínguez-López ME; Ruiz-de-Adana S; Olveira G; Soriguer F
    Diabetes Technol Ther; 2010 Apr; 12(4):263-9. PubMed ID: 20210564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.